You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 12, March 25, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Consensus Statement
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (115)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Tuberculosis/ Other Mycobacterium
 •Drug Therapy
 •Adherence
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Directly Observed Therapy for Treatment Completion of Pulmonary Tuberculosis

Consensus Statement of the Public Health Tuberculosis Guidelines Panel

C. Patrick Chaulk, MD, MPH; Vahe A. Kazandjian, PhD, MPH; for the Public Health Tuberculosis Guidelines Panel

JAMA. 1998;279:943-948.

Objective.— To evaluate evidence on the relative effectiveness of directly observed therapy in achieving treatment completion for pulmonary tuberculosis.

Participants.— A panel of 11 practitioners representing the public health, behavioral, and clinical management of tuberculosis was convened by the Council on Linkages Between Academia and Public Health Practice in 1995 to develop public health guidelines for tuberculosis treatment completion.

Evidence.— English-language articles identified through MEDLINE (1966 to August 1, 1996) with original data on directly observed therapy, supervised therapy, compliance, treatment completion, case management, and treatment adherence for tuberculosis.

Consensus Process.— Each eligible article underwent structured review by at least 2 panel members for study design, sample size, evaluation methods, and treatment completion as the primary outcome. The full panel was convened twice, with intercurrent small group meetings, conference calls, and summary workshop to review findings. Recommendations made through this process were drafted by the panel chair and circulated twice for additional panel comments.

Conclusions.— Treatment completion rates for pulmonary tuberculosis are most likely to exceed 90%, as recommended by the Centers for Disease Control and Prevention, when treatment is based on a patient-centered approach using directly observed therapy with multiple enablers and enhancers. Other less intensive interventions, including nonsupervised strategies and modified approaches to directly observed therapy, are unlikely to achieve this recommended treatment completion goal. Directly observed therapy also appears to be cost-effective compared with self-administered therapy, although data on cost-effectiveness are limited.


From the Annie E. Casey Foundation (Dr Chaulk), the Johns Hopkins Schools of Hygiene and Public Health (Drs Chaulk and Kazandjian) and Medicine (Dr Chaulk), and the Center for Performance Sciences, Inc (Dr Kazandjian), Baltimore, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Direct observation and completion of treatment of tuberculosis in rural areas of China
Jianming Wang and Hongbing Shen
Scand J Public Health 2009;37:304-309.
ABSTRACT  

Hospital-Based Directly Observed Therapy for HIV-Infected Children and Adolescents to Assess Adherence to Antiretroviral Medications
Glikman et al.
Pediatrics 2007;119:e1142-e1148.
ABSTRACT | FULL TEXT  

Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia.
Ignatova et al.
J Med Microbiol 2006;55:1413-1418.
ABSTRACT | FULL TEXT  

Advances in the diagnosis and treatment of tuberculosis.
Nahid et al.
Proc Am Thorac Soc 2006;3:103-110.
ABSTRACT | FULL TEXT  

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States
Am. J. Respir. Crit. Care Med. 2005;172:1169-1227.
FULL TEXT  

Update on the Treatment of Tuberculosis and Latent Tuberculosis Infection
Blumberg et al.
JAMA 2005;293:2776-2784.
ABSTRACT | FULL TEXT  

Adverse Events and Treatment Completion for Latent Tuberculosis in Jail Inmates and Homeless Persons
Lobato et al.
Chest 2005;127:1296-1303.
ABSTRACT | FULL TEXT  

Tuberculosis Treatment Outcomes: Directly Observed Therapy Compared with Self-Administered Therapy
Jasmer et al.
Am. J. Respir. Crit. Care Med. 2004;170:561-566.
ABSTRACT | FULL TEXT  

Pathology Quiz Case 1--Diagnosis
Arch Otolaryngol Head Neck Surg 2004;130:992-993.
FULL TEXT  

What Is Known About the Cost-Effectiveness of Health Services for Returning Prisoners?
Howell et al.
J Correct Health Care 2004;10:399-436.
ABSTRACT  

Directly observed treatment for tuberculosis
Garner and Volmink
BMJ 2003;327:823-824.
FULL TEXT  

Tuberculosis and HIV: A Partnership Against the Most Vulnerable
Cahn et al.
J Int Assoc Physicians AIDS Care (Chic Ill) 2003;2:106-123.
ABSTRACT  

Health Care in America: Lost Opportunities Amid Plenty
Whalen
Qual Health Res 2003;13:857-870.
ABSTRACT  

Field-Delivered Therapy Increases Treatment for Chlamydia and Gonorrhea
Steiner et al.
Am. J. Public Health 2003;93:882-884.
ABSTRACT | FULL TEXT  

Current medical treatment for tuberculosis
Ormerod et al.
BMJ 2003;326:550-550.
FULL TEXT  

Urine Color Test to Monitor Isoniazid Compliance: "Pissin' in the Wind"?
Hollender et al.
Chest 2003;123:668-670.
FULL TEXT  

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis
Am. J. Respir. Crit. Care Med. 2003;167:603-662.
FULL TEXT  

Current medical treatment for tuberculosis
Chan and Iseman
BMJ 2002;325:1282-1286.
FULL TEXT  

Management of Tuberculosis in the United States
Small and Fujiwara
NEJM 2001;345:189-200.
FULL TEXT  

The Language of Medication-Taking
Steiner and Earnest
ANN INTERN MED 2000;132:926-930.
FULL TEXT  

Tuberculosis Screening of Immigrants to Low-Prevalence Countries . A Cost-effectiveness Analysis
SCHWARTZMAN and MENZIES
Am. J. Respir. Crit. Care Med. 2000;161:780-789.
ABSTRACT | FULL TEXT  

Modified Directly Observed Therapy for Treatment of Human Immunodeficiency Virus
Mitty et al.
JAMA 1999;282:1334-1334.
FULL TEXT  

Guidelines in Pulmonary Medicine: A 25-Year Profile
Hackner et al.
Chest 1999;116:1046-1062.
ABSTRACT | FULL TEXT  

Cost-effectiveness Analysis of Directly Observed Therapy for Patients with Tuberculosis at Low Risk for Treatment Default
SNYDER and CHIN
Am. J. Respir. Crit. Care Med. 1999;160:582-586.
ABSTRACT | FULL TEXT  

Tuberculosis: 8. The disease in association with HIV infection
FitzGerald and Houston
CMAJ 1999;161:47-51.
ABSTRACT | FULL TEXT  

Tuberculosis Prevention in Methadone Maintenance Clinics . Effectiveness and Cost-Effectiveness
SNYDER et al.
Am. J. Respir. Crit. Care Med. 1999;160:178-185.
ABSTRACT | FULL TEXT  

Other Articles Noted
Evid. Based Nurs. 1998;1:100-104.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.